The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

Gilead's once-yearly injectable lenacapavir shows promising results in HIV prevention, with a 96% reduction in infections and plans for regulatory filings by 2027.

Musk has argued in favor of regulating AI. But venture capitalists like Andreessen, who founded Andreessen Horowitz, a VC ...

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

A new study has revealed that daily oral antiretrovirals, like Truvada, are highly effective at preventing HIV when taken consistently alongside regular medical check-ups but their efficacy ...

A post on Facebook claims that a new cure for Acquired immunodeficiency syndrome (AIDS) has been discovered and will cost $40 ...

Dr. Greg Shay is a pediatric pulmonologist, a children's lung specialist, with the NGO MedGlobal who has just returned from a ...

Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

The company anticipates it could file for regulatory approval in late 2027. The drug is another formulation of lenacapavir, a ...

Numbers put us in the know. We saw that with COVID-19, and now again, with Rwanda snuffing out the Marburg virus outbreak in ...